Table 1.
Characteristics of obese patients with NAFLD (n 80)
| Parameter | Mean+/−SD or median plus (25–75 IQR) | Parameter | Mean+/−SD or median plus (25–75 IQR) |
|---|---|---|---|
| Age (years) | 46 (34–53) | HDL Females mg/dL | 49.3+/−15 |
| Gender M/F | 36/44 | HDL Males mg/dL | 42.7+/−9 |
| Obesity Degree I/II/III (n) | 18/26/46 | TG mg/dL | 123.5 (83.5-188) |
| BMI | 42.3 (38.1-46.8) | CRP mg/mL | 0.56 (0.27-1.3) |
| WC Females (cm) | 118.9+/−12.5 | Fibrinogen g/L | 295.5 (256–357.5) |
| WC Males (cm) | 129.3+/−14 | Ferritin Females ng/mL | 41.5 (20–69) |
| WHR Females | 0.95 (0.93-0.97 | Ferritin Males ng/mL | 167.5 (85–234) |
| WHR Males | 0.98 (0.96-1) | SLD cm | 11.3+/−1.5 |
| HS Grade 1/2/3 at US (n) | 22/48/10 | RMR | 2352.2+/−432.7 |
| SAT (cm) | 2.6 (2.1-3.1) | Eotaxin pg/mL | 24.6 (6.17-77.5) |
| VAT (cm) | 7.5 (6–9.4) | TNF- α pg/mL | 41.8 (8.1-112.7) |
| ImTG Score I/II/III/IV at US(n) | 11/23/30/16 | IL-6 pg/mL | 5.7 (2.3-17.5) |
| ALT (U/L) | 28 (21.5-29) | IL-8 pg/mL | 23.1 (3.3-68.1) |
| CHE (U/L) | 9671.4+/−1882.2 | IFN-γ pg/mL | 158 (56–390) |
| AP (U/L) | 73 (61–91) | IP-10 (CXCL10) pg/mL | 405 (255–659) |
| γ-GT(U/L) | 25 (16.5-42.5) | MIP-1β (CCL4) pg/mL | 37.2 (24.3-51.9) |
| HS grade at US 1/2/3 (n) | 22/50/8 | Fasting insulin μU/mL | 10.9 (7.5-15.8) |
| IMT (mm) | 0.09 (0.07-011) | Fasting glucose mg/dL | 96.5 (87–114) |
| SBP mm Hg | 130 (120–140) | HOMA | 2.78 (1.85-4.18) |
| DBP mm Hg | 80 (80–90) | LDL | 66.8 (33.3-140) |
| Smoking status (yes/no) | 42/38 |
Waist Circumference WC, Body Mass Index BMI, Waist to Hip ratio WHR, Subcutaneous Adipose Tissue SAT, Visceral Adipose Tissue VAT, High Density Lipoprotein-cholesterol HDL, Low Density Lipoprotein LDL, TriGlycerides TG, C Reactive Protein CRP, Spleen Longitudinal Diameter SLD, Tumor Necrosis Factor alpha TNF-α, Interleukin-6 IL-6, Interleukin-8 IL-8, C-X-C motif chemokine 10 (CXCL10) also known as Interferon Gamma-induced protein 10 (IP-10) CXCL10/IP-10, Chemokine (C-C motif) ligand 4 CCL4/MIP1β, Interferon-Gamma IFN-γ UltraSound US, ALanine aminoTransferase ALT, CHolinEsterase CHE, Alkaline Phosphatase AP, Gamma-Glutamyl Transglutaminase γ-GT, fasting glucose, High Density Lipoprotein cholesterol HDL, HOmeostatic Metabolic Assessment HOMA, Systolic Blood Pressure SPP, Diastolic Blood Pressure DBP, Intima-Media Thickness IMT Resting Metabolic Rate RMR, Intramuscular Triglyceride (TG) storage Score ImTG.